What's Going On With Vor Biopharma Shares Friday? Vor shares are higher lower on Friday after the company announced it has entered into a securities purchase agreement for a private investment in public equity financing.
What's Going On With Penny Stock Blood Cancer-Focused Vor Biopharma On Friday? Vor Biopharma reveals promising Phase 1/2 study results for AML treatment, and it is planning FDA pivotal trial discussions.
VOR Stock Earnings: Vor Biopharma Beats EPS for Q2 2024 VOR stock results show that Vor Biopharma beat analyst estimates for earnings per share the second quarter of 2024.
VOR Stock Earnings: Vor Biopharma Beats EPS for Q1 2024 VOR stock results show that Vor Biopharma beat analyst estimates for earnings per share the first quarter of 2024.
The Penny Stock A-List: 7 High-Profile Companies on the Verge of Greatness Although speculation can be bad for your blood pressure, these compelling penny stocks have some strong endorsements.
VOR Stock Earnings: Vor Biopharma Beats EPS for Q4 2023 VOR stock results show that Vor Biopharma beat analyst estimates for earnings per share the fourth quarter of 2023.
Stocks That Hit 52-Week Lows On Thursday During the session on Thursday, 461 stocks hit new 52-week lows.
Stocks That Hit 52-Week Lows On Tuesday During Tuesday's session, 275 companies made new 52-week lows.
Stocks That Hit 52-Week Lows On Wednesday Wednesday's session saw 43 companies set new 52-week lows.
Stocks That Hit 52-Week Lows On Friday During the Friday's sesion, 157 stocks hit new 52-week lows.
Top 5 Health Care Stocks That Could Lead To Your Biggest Gains In July The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Vor Bio's Trem-cel Shows Early Encouraging Data In Leukemia Patients Vor Biopharma Inc (
NASDAQ: VOR ) presented updated data from patients treated in the VBP101 Phase 1/2a study of trem-cel (formerly VOR33) in
